Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Horacio Plotkin

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolismFrank Rauch, Horacio Plotkin, Rose Travers, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2002
Bone mineralization in polyostotic fibrous dysplasia: histomorphometric analysisLeonieke Terpstra, Frank Rauch, Horacio Plotkin, et al.
Developmental Medicine and Child Neurology|August 15, 2006
Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot studyHoracio Plotkin, Susan Coughlin, Rose Kreikemeier, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2003
Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of boneHoracio Plotkin, Frank Rauch, Leonid Zeitlin, et al.
Medicina|September 28, 2002
Comparable bioavailability of two esophago-gastric protective formulations containing pamidronate. A cross-over trial in healthy young adultsEmilio J A Roldán, Oscar Quattrocchi, Jose Zanchetta, et al.
British Journal of Clinical Pharmacology|August 8, 2024
Nedosiran population pharmacokinetic and pharmacodynamic modelling and simulation to guide clinical development and dose selection in patients with primary hyperoxaluria type 1Steven Zhang, Aniruddha Amrite, Beesan Tan, et al.
Pediatrics|May 3, 2003
Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfectaKathleen Montpetit, Horacio Plotkin, Frank Rauch, et al.
Sub-Cellular Biochemistry|July 30, 2015
Recombinant Enzyme Replacement Therapy in HypophosphatasiaChristine Hofmann, Franz Jakob, Lothar Seefried, et al.
Journal of Pediatric Orthopedics|April 16, 2005
Bone healing in children with osteogenesis imperfecta treated with bisphosphonatesJavier Pizones, Horacio Plotkin, Jose Ignacio Parra-Garcia, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|April 30, 2008
Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official PositionsFrank Rauch, Horacio Plotkin, Linda DiMeglio, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolismFrank Rauch, Horacio Plotkin, Rose Travers, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2002
Bone mineralization in polyostotic fibrous dysplasia: histomorphometric analysisLeonieke Terpstra, Frank Rauch, Horacio Plotkin, et al.
Developmental Medicine and Child Neurology|August 15, 2006
Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot studyHoracio Plotkin, Susan Coughlin, Rose Kreikemeier, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2003
Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of boneHoracio Plotkin, Frank Rauch, Leonid Zeitlin, et al.
Medicina|September 28, 2002
Comparable bioavailability of two esophago-gastric protective formulations containing pamidronate. A cross-over trial in healthy young adultsEmilio J A Roldán, Oscar Quattrocchi, Jose Zanchetta, et al.
British Journal of Clinical Pharmacology|August 8, 2024
Nedosiran population pharmacokinetic and pharmacodynamic modelling and simulation to guide clinical development and dose selection in patients with primary hyperoxaluria type 1Steven Zhang, Aniruddha Amrite, Beesan Tan, et al.
Pediatrics|May 3, 2003
Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfectaKathleen Montpetit, Horacio Plotkin, Frank Rauch, et al.
Sub-Cellular Biochemistry|July 30, 2015
Recombinant Enzyme Replacement Therapy in HypophosphatasiaChristine Hofmann, Franz Jakob, Lothar Seefried, et al.
Journal of Pediatric Orthopedics|April 16, 2005
Bone healing in children with osteogenesis imperfecta treated with bisphosphonatesJavier Pizones, Horacio Plotkin, Jose Ignacio Parra-Garcia, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|April 30, 2008
Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official PositionsFrank Rauch, Horacio Plotkin, Linda DiMeglio, et al.
Pageof 3